Tatiana Alexeev
Glenview, ILNPI 1902268410
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $106,963 of the $120,354 with a category attached, or 88.9%. AbbVie accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest.
Across 268 payments — averaging $449.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$120K
- Galderma Laboratories, L.p.$156
What the payments were for
- Consulting fees$1680%
- Speaking & faculty fees$106,96389%
- Travel & lodging$6,2165%
- Food & beverage$6,7826%
- Education$2260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 259 | $120,197 |
| Galderma Laboratories, L.p. | 9 | $156 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$37,872
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.